Form 4 for VNDA Vanda Pharmaceuticals Inc.
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-08 · accession 0001209191-23-036285 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-12 | 2023-06-08 | VNDA | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +17.3K | 35.8K | +93% | $0 |
| D | 2023-06-12 | 2023-06-08 | VNDA | Mitchell Stephen Ray | Dir | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-08 | A | A | 17,307 | $0.00 | 35,828 | D | — | — | (F1) Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. |
| 2 | Derivative | Stock Option (right to buy) | 2023-06-08 | A | A | 33,960 | $0.00 | 33,960 | D | $6.50 · — to 2033-06-07 | 33,960 Common Stock | (F2) This option vests and becomes exercisable with respect to 100% of the option shares on June 8, 2024, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date. |